ARCHIVES

FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin

This article is from The Cancer Letter archive.

Vol. 11 No. 14 | April 5, 1985

Download PDF Visit The Full Archive

Related Articles

Garb’s Fight Now A Personal One

March 20, 1981

NCCS Appointment Marks Transition To New Structure.

March 17, 2000

In Brief: Cancer Research Institute to Support AIDS Grants, With Maximum $70,000 Each; Deadline Is Oct. 1

July 15, 1983

A Misdirected Email: CPRIT Official Speaks of “New Regime” As Institute Denies Deepening Crisis

October 19, 2012

How NCI Plans To Spend Funds In FY 1980

July 14, 1978

NCAB Says President’s Budget Would “Seriously Damage” Cancer Program

February 12, 1999